Abstract: A safety lid for an aerosol container, including a dome surrounding at least part of a diffuser device and provided with a movable component, which can move between a first position for preventing the operation of the diffuser device, a second position for intermittently activating the diffuser device and a third position for emptying the container. The movable component including means for permanently activating the diffuser device in the third position.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: Various implementations include devices, systems and approaches for tracking user orientation. In some cases, a wearable audio device includes: an electro-acoustic transducer for providing an audio output; an inertial measurement unit (IMU) for indicating motion of the wearable audio device; a set of distance sensors; and a controller coupled with the electro-acoustic transducer, the IMU and the set of distance sensors, the controller configured to: determine an orientation of a user of the wearable audio device based on the indication of motion from the IMU; verify the orientation of the user as detected by the IMU, using data from the set of distance sensors; and execute an orientation-based action in response to verifying the orientation of the user.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: A recyclable aerosol can including a barrel, a dome, a valve support and a base. The base of the can is perforated at the centre thereof with a hole receiving an elastomer insert or plug crimped in the hole. The insert includes an upper part and a lower part joined by a constriction in order to be accommodated in the peripheral wall of the hole in order to form a sealed plug once inserted into the hole.

Abstract: A safety lid for an aerosol container, including a dome surrounding at least part of a diffuser device and provided with a movable component, which can move between a first position for preventing the operation of the diffuser device, a second position for intermittently activating the diffuser device and a third position for emptying the container. The movable component including means for permanently activating the diffuser device in the third position.

Abstract: Various implementations include devices, systems and approaches for tracking user orientation. In some cases, a wearable audio device includes: an electro-acoustic transducer for providing an audio output; an inertial measurement unit (IMU) for indicating motion of the wearable audio device; a set of distance sensors; and a controller coupled with the electro-acoustic transducer, the IMU and the set of distance sensors, the controller configured to: determine an orientation of a user of the wearable audio device based on the indication of motion from the IMU; verify the orientation of the user as detected by the IMU, using data from the set of distance sensors; and execute an orientation-based action in response to verifying the orientation of the user.

Abstract: The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.

Abstract: According to an aspect of the disclosure, a user input device is provided comprising a substrate configured to couple to a user, at least one sensing unit, the at least one sensing unit being coupled to the substrate and being configured to provide an output signal indicative of an amount of deformation of the substrate, and a controller coupled to the at least one sensing unit, the controller being configured to receive, from the at least one sensing unit, the output signal, and determine, based on the output signal, at least one gesture performed by the user.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: A system comprises a wearable item comprising a film of an electrically active material configured to exhibit one or more electrical properties that vary responsive to a movement or gesture performed by a user wearing the wearable item and a controller configured to read the one or more electrical properties of the electrically active material and to activate a control function of an electronic device responsive to detecting a predetermined pattern exhibited by the one or more electrical properties of the electrically active material.

Abstract: A system comprises a wearable item comprising a film of an electrically active material configured to exhibit one or more electrical properties that vary responsive to a movement or gesture performed by a user wearing the wearable item and a controller configured to read the one or more electrical properties of the electrically active material and to activate a control function of an electronic device responsive to detecting a predetermined pattern exhibited by the one or more electrical properties of the electrically active material.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Abstract: A steerable-thrust Hall effect thruster in which a final stage of a magnetic circuit includes an inner pole and a facing outer pole, the inner pole being offset axially downstream relative to the outer pole, so that a magnetic field is inclined relative to a transverse plane of the thruster.